
Incyte to Showcase Groundbreaking Hematology/Oncology Data at EHA 2025
WILMINGTON, DE — Incyte (Nasdaq: INCY) is set to present pivotal data from its hematology/oncology portfolio at the 2025 European Hematology Association (EHA) Congress, scheduled for June 12–15 in Milan. …
Incyte to Showcase Groundbreaking Hematology/Oncology Data at EHA 2025 Read More